Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In a busy time on the GLP-1 front, Novo Nordisk on Tuesday reported filing 14 new lawsuits against companies it says are selling unsafe and unapproved compounded drugs claiming to contain semaglutide, the component of its Ozempic and Wegovy meds
"The market is constantly evolving and at GNC, we are leading the way in product strategy and development to help our customers achieve their wellness goals especially for GLP-1 users," said Rachel Jones, SVP, Chief Product Innovation and Science Officer, GNC
Common violations include poor manufacturing practices, false product claims, selling misbranded items, or marketing unapproved products
Expiration dates are firm safety cutoffs, not suggestions
An unopened vial of bacteriostatic water is a different story
